Combination therapy targeting both innate and adaptive immunity improves survival in a pre-clinical model of ovarian cancer

ConclusionsThis work highlights the importance of CD4+ T cells in tumor immunology. Furthermore, the data support the initiation of clinical trials in ovarian cancer that target both innate and adaptive immunity, with a focus on optimizing dosing schedules.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research